CAR-T specialist Caribou culls pipeline and seeks exit deal
Caribou Biosciences, a biotech developing off-the-shelf cell therapies for blood cancers, said it will discontinue its pipeline and lay off…
News
KymaThera pulls in $80m to bring breast cancer drug to clinic
Rocket receives $150m credit facility to advance cardiovascular portfolio
Gilead Sciences signs five-year DevOps agreement with Cognizant
Shionogi bolsters rare disease portfolio with $2bn IntraBio buyout
Lilly deepens ties with Gate Bioscience in $870m deal expansion
Alector shares up after sealing $1.27bn Roche Parkinson’s disease license deal
CSL and Alentis ink $1.5bn partnership to progress antifibrotic drug
